Natalia Przysucha, Katarzyna Górska, Rafal Krenke Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, PolandCorrespondence: Katarzyna GórskaDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1A, Warsaw 02-097 Email drkpgorska@gmail.comAbstract: Chitinases, enzymes that cleave chitin’s chain to low molecular weight chitooligomers, are widely distributed in nature. Mammalian chitinases belong to the 18-glycosyl-hydrolase family and can be divided into two groups: true chitinases with enzymatic activity (AMCase and chitotriosidase) and chitinase-like proteins (CLPs) molecules which can bind to chitin or chitooligosaccharides but lack enzymatic activity (eg, YKL-40). Chitinases are thought to be part of an innate immunity against chitin-containing parasites and fungal infections. Both groups of these hydrolases are lately evaluated also as chemical mediators or biomarkers involved in airway inflammation and fibrosis. The aim of this article is to present the current knowledge on the potential role of human chitinases and CLPs in the pathogenesis, diagnosis, and course of obstructive lung diseases. We also assessed the potential role of chitinase and CLPs inhibitors as therapeutic targets in chronic obstructive pulmonary disease and asthma.Keywords: asthma, COPD, YKL-40, CHIT1, chitotriosidase, AMCase
PDF full text from Publisher 
Full Text Finder